The accumulation of beta-hydroxy butyric acid could trigger severe steatohepatitis and then promote liver fibrosis progression (Liao et al., 2021), however, the lack of this substance will result in inflammation response and liver injury indirectly PI3K-Akt pathway (Miyauchi et al., 2019). Here, AKT1 is linked to Hepatic fibrosis.